Related Experiment Videos
[Characteristics of memory in MRL/1 mice and the effect of thymic peptides]
Abstract:
By means of methods of active and passive getting rid of electrical-pain irritation we showed that in mice MRL/1--the model of rheumatoid arthritis (RA)--as compared with CBA (control) the process of forming a developed habit engram (DHE) was slowed down and its keeping was impaired. Thymic peptides (thymalin--0.2 mlg/mice intraperitoneally) suppressed the process of forming DHE irrespective of mice line and improved the process of its consolidation and keeping especially in mice MRL/1. Memory impairment in mice with genetical predisposition to the development of autoimmune process (MRL/1) is considered from view of the authors' developed hypothesis about thymus as an organ of antisystem of immune control of homeostasis and RA as an adaptation disease.
Insights
Rheumatoid arthritis (RA) impairs memory formation in MRL/1 mice. Thymic peptides like thymalin improved memory consolidation and retention, especially in RA-prone mice.
Area of Science:
- Neuroimmunology
- Immunology
- Behavioral Neuroscience
Background:
- Rheumatoid arthritis (RA) is an autoimmune disease.
- Memory deficits are observed in individuals with autoimmune conditions.
- The MRL/1 mouse strain serves as a model for RA.
Purpose of the Study:
- To investigate the impact of rheumatoid arthritis on memory formation and retention.
- To evaluate the therapeutic potential of thymic peptides in mitigating memory impairment associated with RA.
Main Methods:
- Utilized active and passive avoidance methods to assess memory.
- Administered thymic peptides (thymalin) intraperitoneally to mice.
- Compared memory processes in MRL/1 mice (RA model) with CBA mice (control).
Main Results:
- Mice with rheumatoid arthritis (MRL/1) exhibited delayed formation and impaired retention of developed habit engrams (DHE) compared to control mice.
- Thymalin administration suppressed DHE formation across both mouse strains.
- Thymalin significantly enhanced DHE consolidation and retention, particularly in MRL/1 mice.
Conclusions:
- Memory impairment in MRL/1 mice is linked to their genetic predisposition to autoimmune processes.
- Thymus-derived peptides demonstrate a therapeutic effect on memory deficits in an autoimmune disease model.
- The findings support the hypothesis of the thymus as a key regulator of immune homeostasis and suggest RA may be an adaptation disease.